Prediction of non-muscle-invasive bladder cancer recurrence by measurement of checkpoint HLAG's receptor ILT2 on peripheral CD8+ T cells.

Conclusions: We demonstrated a strong association between the proportion of circulating CD8+ILT2+ T cells and NMIBC risk of recurrence. Gain in prediction was substantial. If externally validated, such immunological marker could be integrated to predict NMIBC recurrence. PMID: 30237859 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/30237859?dopt=Abstract

Source: Oncotarget - September 23, 2018 Category: Cancer & Oncology Tags: Oncotarget Source Type: research